Shopping Cart 0
Cart Subtotal
USD 0

WuXi NextCODE Genomics - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database architecture, which enables clinicians and researchers across the globe to use the power of next-generation sequencing data to better diagnose and treat diseases. WuXi NextCODE's services comprise genome analysis and interpretation, big data management and storage, custom integration and next generation sequencing. It has operations in Shanghai, Cambridge and Reykjavik. WuXi NextCODE is headquartered in Cambridge, Massachusetts, the US.

WuXi NextCODE Genomics-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

DNAnexus Raises USD58 Million in Equity Financing 11

WuXi NextCODE Raises Additional USD165 Million in Series B Financing 13

NextCode Health Raises USD15 Million in Series A Financing 14

Partnerships 15

WuXi NextCode Enters into Partnership with Rhythm Pharma 15

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 16

Genomics England Enters into Contract Agreement with WuXi NextCODE 17

SA1KCGP, WuXi NextCODE and START Enter into Partnership 18

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 19

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 20

Acquisition 21

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 21

WuXi NextCODE Genomics-Key Competitors 22

WuXi NextCODE Genomics-Key Employees 23

WuXi NextCODE Genomics-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Corporate Communications 25

Apr 15, 2018: WuXi NextCODE Appoints Richard Williams As Managing Director And Head Of Oncology Programs 25

Mar 12, 2018: WuXi NextCODE Appoints Rob Brainin As Chief Executive Officer 26

Feb 28, 2017: WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO 27

Government and Public Interest 28

Feb 28, 2017: China plans leading role in 'precision medicine' field 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Key Facts 2

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Deals By Therapy Area, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9

WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

DNAnexus Raises USD58 Million in Equity Financing 11

WuXi NextCODE Raises Additional USD165 Million in Series B Financing 13

NextCode Health Raises USD15 Million in Series A Financing 14

WuXi NextCode Enters into Partnership with Rhythm Pharma 15

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 16

Genomics England Enters into Contract Agreement with WuXi NextCODE 17

SA1KCGP, WuXi NextCODE and START Enter into Partnership 18

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 19

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 20

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 21

WuXi NextCODE Genomics, Key Competitors 22

WuXi NextCODE Genomics, Key Employees 23

WuXi NextCODE Genomics, Other Locations 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

WuXi NextCODE Genomics, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.